Cervus elaphus chromosome 17, mCerEla1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Artiodactyla; Ruminantia; Pecora; Cervidae; Cervinae; Cervus.
REFSEQ INFORMATION: The reference sequence is identical to\nOU343094.1.\nAssembly name: mCerEla1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2021/07/07. The original whole-genome shotgun project has the\naccession CAJVBL000000000.1.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Cervus elaphus Annotation Release\n 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
apelin receptor early endogenous ligand, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
apelin receptor early endogenous ligand, transcript variant X1
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA phenylalanine (anticodon AAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
membrane associated ring-CH-type finger 1, transcript variant X1
transfer RNA cysteine (anticodon ACA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins
E3 ubiquitin-protein ligase MARCHF1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
membrane associated ring-CH-type finger 1, transcript variant X2
E3 ubiquitin-protein ligase MARCHF1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
translation machinery associated 16 homolog
translation machinery-associated protein 16
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01268
neuropeptide Y receptor Y1, transcript variant X2
neuropeptide Y receptor Y1, transcript variant X1
neuropeptide Y receptor Y1, transcript variant X3
nuclear assembly factor 1 ribonucleoprotein
H/ACA ribonucleoprotein complex non-core subunit NAF1
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA cysteine (anticodon GCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
pyroglutamylated RFamide peptide receptor
pyroglutamylated RF-amide peptide receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
neuron derived neurotrophic factor, transcript variant X2
neuron derived neurotrophic factor, transcript variant X1
PR domain zinc finger protein 5 isoform X1
PR domain zinc finger protein 5 isoform X2
PR domain zinc finger protein 5 isoform X3
PR domain zinc finger protein 5 isoform X4
uncharacterized LOC122673316, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122673316, transcript variant X1
mitotic spindle assembly checkpoint protein MAD2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X4
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X2
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
cGMP-specific 3',5'-cyclic phosphodiesterase-like, transcript variant X6
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X4
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X2
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X3
cGMP-specific 3',5'-cyclic phosphodiesterase-like isoform X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
mitotic spindle assembly checkpoint protein MAD2A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
T-cell activation Rho GTPase-activating protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 11 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 46% coverage of the annotated genomic feature by RNAseq alignments
phosphodiesterase 5A, transcript variant X1
phosphodiesterase 5A, transcript variant X4
cGMP-specific 3',5'-cyclic phosphodiesterase isoform X1
cGMP-specific 3',5'-cyclic phosphodiesterase isoform X4
phosphodiesterase 5A, transcript variant X3
phosphodiesterase 5A, transcript variant X2
cGMP-specific 3',5'-cyclic phosphodiesterase isoform X2
cGMP-specific 3',5'-cyclic phosphodiesterase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
40S ribosomal protein S24-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 23 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
40S ribosomal protein S24-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
40S ribosomal protein S24-like isoform X2
40S ribosomal protein S24-like isoform X1
inactive ubiquitin carboxyl-terminal hydrolase 53
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
SEC24 homolog D, COPII coat complex component, transcript variant X1
SEC24 homolog D, COPII coat complex component, transcript variant X4
SEC24 homolog D, COPII coat complex component, transcript variant X2
SEC24 homolog D, COPII coat complex component, transcript variant X3
protein transport protein Sec24D isoform X1
protein transport protein Sec24D isoform X2
methyltransferase 14, N6-adenosine-methyltransferase subunit
N6-adenosine-methyltransferase non-catalytic subunit
40S ribosomal protein S27-like, transcript variant X2
40S ribosomal protein S27-like, transcript variant X1
40S ribosomal protein S27-like isoform X1
40S ribosomal protein S27-like isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00399
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 37% coverage of the annotated genomic feature by RNAseq alignments
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3, transcript variant X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3, transcript variant X2
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3, transcript variant X3
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 isoform X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 isoform X2
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
translocation associated membrane protein 1 like 1
translocating chain-associated membrane protein 1-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
collagen alpha-1(III) chain-like, transcript variant X1
collagen alpha-1(III) chain-like, transcript variant X4
collagen alpha-1(III) chain-like, transcript variant X5
collagen alpha-1(III) chain-like, transcript variant X7
collagen alpha-1(III) chain-like, transcript variant X6
collagen alpha-1(III) chain-like, transcript variant X3
collagen alpha-1(III) chain-like, transcript variant X2
collagen alpha-1(III) chain-like isoform X2
collagen alpha-1(III) chain-like isoform X4
collagen alpha-1(III) chain-like isoform X6
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4, transcript variant X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4, transcript variant X2
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 isoform X1
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 isoform X2
2-hydroxyacylsphingosine 1-beta-galactosyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins
protein PBDC1-like, transcript variant X1
protein PBDC1-like, transcript variant X2
uncharacterized protein LOC122673395 isoform X2
uncharacterized LOC122673514, transcript variant X2
uncharacterized LOC122673514, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122673459, transcript variant X2
uncharacterized LOC122673459, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 21% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122673292, transcript variant X2
uncharacterized LOC122673292, transcript variant X3
uncharacterized LOC122673292, transcript variant X1
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
heterogeneous nuclear ribonucleoproteins A2/B1-like
calcium/calmodulin dependent protein kinase II delta, transcript variant X12
calcium/calmodulin dependent protein kinase II delta, transcript variant X7
calcium/calmodulin dependent protein kinase II delta, transcript variant X5
calcium/calmodulin dependent protein kinase II delta, transcript variant X1
calcium/calmodulin dependent protein kinase II delta, transcript variant X6
calcium/calmodulin dependent protein kinase II delta, transcript variant X11
calcium/calmodulin dependent protein kinase II delta, transcript variant X3
calcium/calmodulin dependent protein kinase II delta, transcript variant X15
calcium/calmodulin dependent protein kinase II delta, transcript variant X9
calcium/calmodulin dependent protein kinase II delta, transcript variant X14
calcium/calmodulin dependent protein kinase II delta, transcript variant X8
calcium/calmodulin dependent protein kinase II delta, transcript variant X13
calcium/calmodulin dependent protein kinase II delta, transcript variant X18
calcium/calmodulin dependent protein kinase II delta, transcript variant X2
calcium/calmodulin dependent protein kinase II delta, transcript variant X4
calcium/calmodulin dependent protein kinase II delta, transcript variant X16
calcium/calmodulin dependent protein kinase II delta, transcript variant X10
calcium/calmodulin dependent protein kinase II delta, transcript variant X17
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X6
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X14
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X13
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X7
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X3
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X9
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X8
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X2
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X4
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X10
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X17
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X12
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X5
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X11
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X15
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X18
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X16
La ribonucleoprotein 7, transcriptional regulator, transcript variant X4
La ribonucleoprotein 7, transcriptional regulator, transcript variant X1
La ribonucleoprotein 7, transcriptional regulator, transcript variant X3
La ribonucleoprotein 7, transcriptional regulator, transcript variant X5
La ribonucleoprotein 7, transcriptional regulator, transcript variant X2
La ribonucleoprotein 7, transcriptional regulator, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 17 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
zinc finger GRF-type containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
zinc finger GRF-type containing 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
zinc finger GRF-type containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger GRF-type containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger GRF-type containing 1, transcript variant X3
zinc finger GRF-type containing 1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
zinc finger GRF-type containing 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
TRAF interacting protein with forkhead associated domain
TRAF-interacting protein with FHA domain-containing protein A
adaptor related protein complex 1 associated regulatory protein, transcript variant X2
adaptor related protein complex 1 associated regulatory protein, transcript variant X1
adaptor related protein complex 1 associated regulatory protein, transcript variant X3
AP-1 complex-associated regulatory protein isoform X2
AP-1 complex-associated regulatory protein isoform X1
AP-1 complex-associated regulatory protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
family with sequence similarity 241 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC122673507, transcript variant X2
uncharacterized LOC122673507, transcript variant X1
paired like homeodomain 2, transcript variant X3
paired like homeodomain 2, transcript variant X2
paired like homeodomain 2, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
ELOVL fatty acid elongase 6, transcript variant X2
ELOVL fatty acid elongase 6, transcript variant X1
elongation of very long chain fatty acids protein 6
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 37% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 3 bases in 2 codons; substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: pro-epidermal growth factor
COORDINATES: nucleotide motif:Rfam:12.0:RF00425
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 38% coverage of the annotated genomic feature by RNAseq alignments
leucine rich repeat, Ig-like and transmembrane domains 3, transcript variant X1
leucine rich repeat, Ig-like and transmembrane domains 3, transcript variant X2
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3
retinal pigment epithelium-derived rhodopsin homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
GAR1 ribonucleoprotein, transcript variant X5
GAR1 ribonucleoprotein, transcript variant X3
GAR1 ribonucleoprotein, transcript variant X1
GAR1 ribonucleoprotein, transcript variant X2
GAR1 ribonucleoprotein, transcript variant X4
H/ACA ribonucleoprotein complex subunit 1 isoform X1
H/ACA ribonucleoprotein complex subunit 1 isoform X2
complement factor I, transcript variant X2
complement factor I, transcript variant X1
mitochondrial calcium uniporter dominant negative subunit beta
calcium uniporter regulatory subunit MCUb, mitochondrial
SEC24 homolog B, COPII coat complex component, transcript variant X5
SEC24 homolog B, COPII coat complex component, transcript variant X4
SEC24 homolog B, COPII coat complex component, transcript variant X2
SEC24 homolog B, COPII coat complex component, transcript variant X1
SEC24 homolog B, COPII coat complex component, transcript variant X3
protein transport protein Sec24B isoform X5
protein transport protein Sec24B isoform X4
protein transport protein Sec24B isoform X3
protein transport protein Sec24B isoform X2
protein transport protein Sec24B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 48% coverage of the annotated genomic feature by RNAseq alignments
collagen type XXV alpha 1 chain, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
collagen type XXV alpha 1 chain, transcript variant X19
collagen type XXV alpha 1 chain, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
collagen type XXV alpha 1 chain, transcript variant X12
collagen type XXV alpha 1 chain, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
collagen type XXV alpha 1 chain, transcript variant X6
collagen type XXV alpha 1 chain, transcript variant X13
collagen type XXV alpha 1 chain, transcript variant X1
collagen type XXV alpha 1 chain, transcript variant X22
collagen type XXV alpha 1 chain, transcript variant X8
collagen type XXV alpha 1 chain, transcript variant X4
collagen type XXV alpha 1 chain, transcript variant X23
collagen type XXV alpha 1 chain, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
collagen type XXV alpha 1 chain, transcript variant X18
collagen type XXV alpha 1 chain, transcript variant X21
collagen type XXV alpha 1 chain, transcript variant X20
collagen type XXV alpha 1 chain, transcript variant X17
collagen type XXV alpha 1 chain, transcript variant X2
collagen type XXV alpha 1 chain, transcript variant X3
collagen type XXV alpha 1 chain, transcript variant X10
collagen type XXV alpha 1 chain, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
collagen type XXV alpha 1 chain, transcript variant X11
collagen type XXV alpha 1 chain, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins
oligosaccharyltransferase complex non-catalytic subunit
oligosaccharyltransferase complex subunit OSTC
ribosomal protein L34, transcript variant X3
ribosomal protein L34, transcript variant X1
ribosomal protein L34, transcript variant X6
ribosomal protein L34, transcript variant X4
ribosomal protein L34, transcript variant X2
ribosomal protein L34, transcript variant X5
lymphoid enhancer binding factor 1, transcript variant X2
lymphoid enhancer binding factor 1, transcript variant X1
lymphoid enhancer binding factor 1, transcript variant X4
lymphoid enhancer binding factor 1, transcript variant X3
lymphoid enhancer-binding factor 1 isoform X1
lymphoid enhancer-binding factor 1 isoform X3
lymphoid enhancer-binding factor 1 isoform X2
lymphoid enhancer-binding factor 1 isoform X4
lymphoid enhancer binding factor 1, transcript variant X5
lymphoid enhancer binding factor 1, transcript variant X6
lymphoid enhancer-binding factor 1 isoform X5
lymphoid enhancer-binding factor 1 isoform X6
hydroxyacyl-coenzyme A dehydrogenase, mitochondrial
sphingomyelin synthase 2, transcript variant X2
sphingomyelin synthase 2, transcript variant X3
sphingomyelin synthase 2, transcript variant X4
sphingomyelin synthase 2, transcript variant X1
phosphatidylcholine:ceramide cholinephosphotransferase 2
transfer RNA glycine (anticodon CCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
3'-phosphoadenosine 5'-phosphosulfate synthase 1
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1
transfer RNA glutamic acid (anticodon UUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
dickkopf WNT signaling pathway inhibitor 2, transcript variant X1
dickkopf WNT signaling pathway inhibitor 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 15 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
GIMAP family P-loop NTPase domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
aminoacyl tRNA synthetase complex interacting multifunctional protein 1, transcript variant X1
aminoacyl tRNA synthetase complex interacting multifunctional protein 1, transcript variant X2
aminoacyl tRNA synthase complex-interacting multifunctional protein 1 isoform X1
aminoacyl tRNA synthase complex-interacting multifunctional protein 1 isoform X2
TBC1 domain containing kinase, transcript variant X1
TBC1 domain containing kinase, transcript variant X3
TBC1 domain containing kinase, transcript variant X2
TBC domain-containing protein kinase-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00283
glutathione S-transferase C-terminal domain containing, transcript variant X1
glutathione S-transferase C-terminal domain containing, transcript variant X2
glutathione S-transferase C-terminal domain containing, transcript variant X3
glutathione S-transferase C-terminal domain containing, transcript variant X4
glutathione S-transferase C-terminal domain-containing protein isoform X1
glutathione S-transferase C-terminal domain containing, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutathione S-transferase C-terminal domain-containing protein isoform X2
Rho guanine nucleotide exchange factor 38
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inorganic pyrophosphatase 2, transcript variant X1
inorganic pyrophosphatase 2, transcript variant X2
inorganic pyrophosphatase 2, mitochondrial isoform X1
inorganic pyrophosphatase 2, mitochondrial isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins
oral-facial-digital syndrome 1 protein-like
tet methylcytosine dioxygenase 2, transcript variant X2
tet methylcytosine dioxygenase 2, transcript variant X1
methylcytosine dioxygenase TET2 isoform X2
methylcytosine dioxygenase TET2 isoform X1
tet methylcytosine dioxygenase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 16 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
tet methylcytosine dioxygenase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 16 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
methylcytosine dioxygenase TET2 isoform X3
uncharacterized LOC122673571, transcript variant X1
uncharacterized LOC122673571, transcript variant X2
CXXC finger protein 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
CXXC finger protein 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CXXC finger protein 4, transcript variant X6
CXXC finger protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
CXXC finger protein 4, transcript variant X3
CXXC finger protein 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
CXXC-type zinc finger protein 4 isoform X2
CXXC-type zinc finger protein 4 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 5 ESTs, 14 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
centromere protein E, transcript variant X1
centromere protein E, transcript variant X3
centromere protein E, transcript variant X2
centromere protein E, transcript variant X4
centromere-associated protein E isoform X1
centromere-associated protein E isoform X3
centromere-associated protein E isoform X2
centromere-associated protein E isoform X4
3-hydroxybutyrate dehydrogenase 2, transcript variant X3
3-hydroxybutyrate dehydrogenase 2, transcript variant X1
3-hydroxybutyrate dehydrogenase 2, transcript variant X2
3-hydroxybutyrate dehydrogenase type 2 isoform X1
3-hydroxybutyrate dehydrogenase type 2 isoform X2
solute carrier family 9 member B2, transcript variant X1
solute carrier family 9 member B2, transcript variant X3
solute carrier family 9 member B2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
solute carrier family 9 member B2, transcript variant X2
sodium/hydrogen exchanger 9B2 isoform X1
sodium/hydrogen exchanger 9B2 isoform X2
sodium/hydrogen exchanger 9B2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
CDGSH iron-sulfur domain-containing protein 2
uncharacterized LOC122673198, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC122673198, transcript variant X2
uncharacterized LOC122673198, transcript variant X1
ubiquitin conjugating enzyme E2 D3, transcript variant X4
ubiquitin conjugating enzyme E2 D3, transcript variant X7
ubiquitin conjugating enzyme E2 D3, transcript variant X3
ubiquitin conjugating enzyme E2 D3, transcript variant X1
ubiquitin conjugating enzyme E2 D3, transcript variant X5
ubiquitin conjugating enzyme E2 D3, transcript variant X2
ubiquitin conjugating enzyme E2 D3, transcript variant X6
ubiquitin-conjugating enzyme E2 D3 isoform X2
ubiquitin-conjugating enzyme E2 D3 isoform X1
nuclear factor kappa B subunit 1, transcript variant X2
nuclear factor kappa B subunit 1, transcript variant X1
nuclear factor NF-kappa-B p105 subunit isoform X2
nuclear factor NF-kappa-B p105 subunit isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
solute carrier family 39 member 8, transcript variant X3
solute carrier family 39 member 8, transcript variant X1
solute carrier family 39 member 8, transcript variant X2
B cell scaffold protein with ankyrin repeats 1, transcript variant X3
B cell scaffold protein with ankyrin repeats 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
B cell scaffold protein with ankyrin repeats 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
B cell scaffold protein with ankyrin repeats 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
B-cell scaffold protein with ankyrin repeats isoform X3
B-cell scaffold protein with ankyrin repeats isoform X2
B-cell scaffold protein with ankyrin repeats isoform X1
B-cell scaffold protein with ankyrin repeats isoform X4
leucine-rich repeat extensin-like protein 3
protein phosphatase 3 catalytic subunit alpha, transcript variant X1
protein phosphatase 3 catalytic subunit alpha, transcript variant X2
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
DNA damage-inducible transcript 4-like protein
DnaJ heat shock protein family (Hsp40) member B14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
DnaJ heat shock protein family (Hsp40) member B14, transcript variant X2
DnaJ heat shock protein family (Hsp40) member B14, transcript variant X1
dnaJ homolog subfamily B member 14 isoform X1
dnaJ homolog subfamily B member 14 isoform X2
dnaJ homolog subfamily B member 14 isoform X3
DnaJ heat shock protein family (Hsp40) member B14, transcript variant X4
dnaJ homolog subfamily B member 14 isoform X4
late endosomal/lysosomal adaptor, MAPK and MTOR activator 3
dual adaptor of phosphotyrosine and 3-phosphoinositides 1, transcript variant X2
dual adaptor of phosphotyrosine and 3-phosphoinositides 1, transcript variant X1
dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide isoform X2
dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide isoform X1
chromosome 17 C4orf54 homolog, transcript variant X2
chromosome 17 C4orf54 homolog, transcript variant X1
microsomal triglyceride transfer protein
microsomal triglyceride transfer protein large subunit
tRNA methyltransferase 10A, transcript variant X2
tRNA methyltransferase 10A, transcript variant X4
tRNA methyltransferase 10A, transcript variant X3
tRNA methyltransferase 10A, transcript variant X1
tRNA methyltransferase 10 homolog A isoform X1
tRNA methyltransferase 10 homolog A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
alcohol dehydrogenase 7 (class IV), mu or sigma polypeptide
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: all-trans-retinol dehydrogenase [NAD(+)] ADH7
all-trans-retinol dehydrogenase [NAD(+)] ADH4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 28% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4E, transcript variant X1
eukaryotic translation initiation factor 4E isoform X1
eukaryotic translation initiation factor 4E, transcript variant X3
eukaryotic translation initiation factor 4E isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
eukaryotic translation initiation factor 4E, transcript variant X2
eukaryotic translation initiation factor 4E isoform X2
eukaryotic translation initiation factor 4E, transcript variant X4
eukaryotic translation initiation factor 4E isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 18% coverage of the annotated genomic feature by RNAseq alignments
Rap1 GTPase-GDP dissociation stimulator 1, transcript variant X5
Rap1 GTPase-GDP dissociation stimulator 1, transcript variant X4
Rap1 GTPase-GDP dissociation stimulator 1, transcript variant X2
Rap1 GTPase-GDP dissociation stimulator 1, transcript variant X3
Rap1 GTPase-GDP dissociation stimulator 1, transcript variant X1
rap1 GTPase-GDP dissociation stimulator 1 isoform X5
rap1 GTPase-GDP dissociation stimulator 1 isoform X2
rap1 GTPase-GDP dissociation stimulator 1 isoform X4
rap1 GTPase-GDP dissociation stimulator 1 isoform X3
rap1 GTPase-GDP dissociation stimulator 1 isoform X1
sperm tail PG-rich repeat containing 2, transcript variant X3
sperm tail PG-rich repeat containing 2, transcript variant X2
sperm tail PG-rich repeat containing 2, transcript variant X1
sperm-tail PG-rich repeat-containing protein 2 isoform X2
sperm-tail PG-rich repeat-containing protein 2 isoform X3
sperm-tail PG-rich repeat-containing protein 2 isoform X1
sperm tail PG-rich repeat containing 2, transcript variant X4
sperm-tail PG-rich repeat-containing protein 2 isoform X4
transfer RNA tyrosine (anticodon AUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
pyruvate dehydrogenase E1 subunit alpha 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
pyruvate dehydrogenase E1 subunit alpha 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 7 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial isoform X2
pyruvate dehydrogenase E1 component subunit alpha, testis-specific form, mitochondrial isoform X1
unc-5 netrin receptor C, transcript variant X1
unc-5 netrin receptor C, transcript variant X2
RNA 3'-terminal phosphate cyclase, transcript variant X2
RNA 3'-terminal phosphate cyclase, transcript variant X1
RNA 3'-terminal phosphate cyclase, transcript variant X3
RNA 3'-terminal phosphate cyclase isoform X2
RNA 3'-terminal phosphate cyclase isoform X1
RNA 3'-terminal phosphate cyclase isoform X3
bone morphogenetic protein receptor type 1B, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 26 ESTs, 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 26 ESTs, 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 26 ESTs, 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 26 ESTs, 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 26 ESTs, 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X5
bone morphogenetic protein receptor type 1B, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 26 ESTs, 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X12
bone morphogenetic protein receptor type 1B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 26 ESTs, 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
bone morphogenetic protein receptor type 1B, transcript variant X8
bone morphogenetic protein receptor type 1B, transcript variant X13
bone morphogenetic protein receptor type 1B, transcript variant X9
bone morphogenetic protein receptor type 1B, transcript variant X2
bone morphogenetic protein receptor type-1B isoform X1
bone morphogenetic protein receptor type-1B isoform X2
bone morphogenetic protein receptor type-1B isoform X3
bone morphogenetic protein receptor type-1B isoform X4
PDZ and LIM domain 5, transcript variant X5
PDZ and LIM domain 5, transcript variant X4
PDZ and LIM domain 5, transcript variant X3
PDZ and LIM domain 5, transcript variant X8
PDZ and LIM domain 5, transcript variant X2
PDZ and LIM domain 5, transcript variant X1
PDZ and LIM domain 5, transcript variant X7
PDZ and LIM domain 5, transcript variant X6
uncharacterized LOC122673519, transcript variant X1
uncharacterized LOC122673519, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
hematopoietic prostaglandin D synthase, transcript variant X1
hematopoietic prostaglandin D synthase, transcript variant X3
hematopoietic prostaglandin D synthase, transcript variant X2
hematopoietic prostaglandin D synthase isoform X1
hematopoietic prostaglandin D synthase isoform X2
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1, transcript variant X2
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1, transcript variant X1
SWI/SNF-related, matrix-associated actin-dependent regulator of chromatin, subfamily a, containing DEAD/H box 1, transcript variant X3
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 isoform X2
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily A containing DEAD/H box 1 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
glutamate ionotropic receptor delta type subunit 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate receptor ionotropic, delta-2 isoform X2
glutamate ionotropic receptor delta type subunit 2, transcript variant X1
glutamate receptor ionotropic, delta-2 isoform X1
coiled-coil serine rich protein 1, transcript variant X1
coiled-coil serine rich protein 1, transcript variant X3
coiled-coil serine rich protein 1, transcript variant X2
coiled-coil serine rich protein 1, transcript variant X4
serine-rich coiled-coil domain-containing protein 1 isoform X1
coiled-coil serine rich protein 1, transcript variant X5
serine-rich coiled-coil domain-containing protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
G protein-regulated inducer of neurite outgrowth 3
tigger transposable element-derived protein 2
family with sequence similarity 13 member A, transcript variant X4
family with sequence similarity 13 member A, transcript variant X1
family with sequence similarity 13 member A, transcript variant X5
family with sequence similarity 13 member A, transcript variant X2
family with sequence similarity 13 member A, transcript variant X3
family with sequence similarity 13 member A, transcript variant X8
family with sequence similarity 13 member A, transcript variant X12
family with sequence similarity 13 member A, transcript variant X6
family with sequence similarity 13 member A, transcript variant X7
family with sequence similarity 13 member A, transcript variant X10
family with sequence similarity 13 member A, transcript variant X9
family with sequence similarity 13 member A, transcript variant X11
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant X3
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant X1
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant X2
probable E3 ubiquitin-protein ligase HERC3 isoform X2
probable E3 ubiquitin-protein ligase HERC3 isoform X1
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
HECT and RLD domain containing E3 ubiquitin protein ligase 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
phosphatidylinositol glycan anchor biosynthesis class Y
phosphatidylinositol N-acetylglucosaminyltransferase subunit Y
HECT and RLD domain containing E3 ubiquitin protein ligase 5
probable E3 ubiquitin-protein ligase HERC6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 ESTs, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 ESTs, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC6 isoform X2
probable E3 ubiquitin-protein ligase HERC6 isoform X1
probable E3 ubiquitin-protein ligase HERC6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
probable E3 ubiquitin-protein ligase HERC6 isoform X3
uncharacterized LOC122673225, transcript variant X1
uncharacterized LOC122673225, transcript variant X2
protein phosphatase, Mg2+/Mn2+ dependent 1K, transcript variant X1
protein phosphatase, Mg2+/Mn2+ dependent 1K, transcript variant X2
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X5
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X2
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X3
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X1
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X6
ATP binding cassette subfamily G member 2 (Junior blood group), transcript variant X4
broad substrate specificity ATP-binding cassette transporter ABCG2
polycystin 2, transient receptor potential cation channel
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
matrix extracellular phosphoglycoprotein, transcript variant X2
matrix extracellular phosphoglycoprotein, transcript variant X1
matrix extracellular phosphoglycoprotein isoform X2
matrix extracellular phosphoglycoprotein isoform X1
integrin binding sialoprotein, transcript variant X2
integrin binding sialoprotein, transcript variant X1
integrin binding sialoprotein, transcript variant X3
actin-related protein 2/3 complex subunit 3-like
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
mediator of RNA polymerase II transcription subunit 28
family with sequence similarity 184 member B, transcript variant X2
family with sequence similarity 184 member B, transcript variant X1
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
DDB1 and CUL4 associated factor 16, transcript variant X2
DDB1 and CUL4 associated factor 16, transcript variant X1
DDB1 and CUL4 associated factor 16, transcript variant X3
DDB1 and CUL4 associated factor 16, transcript variant X4
ligand dependent nuclear receptor corepressor like, transcript variant X14
ligand-dependent nuclear receptor corepressor-like protein isoform X10
ligand dependent nuclear receptor corepressor like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ligand dependent nuclear receptor corepressor like, transcript variant X5
ligand dependent nuclear receptor corepressor like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
ligand-dependent nuclear receptor corepressor-like protein isoform X8
ligand-dependent nuclear receptor corepressor-like protein isoform X5
ligand-dependent nuclear receptor corepressor-like protein isoform X1
ligand dependent nuclear receptor corepressor like, transcript variant X4
ligand dependent nuclear receptor corepressor like, transcript variant X3
ligand dependent nuclear receptor corepressor like, transcript variant X9
ligand dependent nuclear receptor corepressor like, transcript variant X10
ligand dependent nuclear receptor corepressor like, transcript variant X8
ligand dependent nuclear receptor corepressor like, transcript variant X6
ligand dependent nuclear receptor corepressor like, transcript variant X2
ligand dependent nuclear receptor corepressor like, transcript variant X11
ligand dependent nuclear receptor corepressor like, transcript variant X7
ligand dependent nuclear receptor corepressor like, transcript variant X13
ligand-dependent nuclear receptor corepressor-like protein isoform X4
ligand-dependent nuclear receptor corepressor-like protein isoform X3
ligand-dependent nuclear receptor corepressor-like protein isoform X2
ligand-dependent nuclear receptor corepressor-like protein isoform X7
ligand-dependent nuclear receptor corepressor-like protein isoform X6
ligand-dependent nuclear receptor corepressor-like protein isoform X9
ligand dependent nuclear receptor corepressor like, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
ligand-dependent nuclear receptor corepressor-like protein isoform X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
slit guidance ligand 2, transcript variant X1
slit guidance ligand 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
parkin coregulated like, transcript variant X2
parkin coregulated like, transcript variant X1
parkin coregulated like, transcript variant X5
parkin coregulated like, transcript variant X4
parkin coregulated like, transcript variant X3
potassium voltage-gated channel interacting protein 4, transcript variant X1
potassium voltage-gated channel interacting protein 4, transcript variant X5
potassium voltage-gated channel interacting protein 4, transcript variant X4
potassium voltage-gated channel interacting protein 4, transcript variant X3
potassium voltage-gated channel interacting protein 4, transcript variant X2
Kv channel-interacting protein 4 isoform X5
Kv channel-interacting protein 4 isoform X1
Kv channel-interacting protein 4 isoform X4
Kv channel-interacting protein 4 isoform X3
Kv channel-interacting protein 4 isoform X2
adhesion G protein-coupled receptor A3, transcript variant X2
adhesion G protein-coupled receptor A3, transcript variant X1
adhesion G protein-coupled receptor A3, transcript variant X3
adhesion G protein-coupled receptor A3 isoform X2
adhesion G protein-coupled receptor A3 isoform X1
adhesion G protein-coupled receptor A3 isoform X3
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cytosolic beta-glucosidase-like
PPARG coactivator 1 alpha, transcript variant X4
PPARG coactivator 1 alpha, transcript variant X2
PPARG coactivator 1 alpha, transcript variant X3
PPARG coactivator 1 alpha, transcript variant X1
PPARG coactivator 1 alpha, transcript variant X5
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X2
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X4
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X3
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X1
peroxisome proliferator-activated receptor gamma coactivator 1-alpha isoform X5
pre-mRNA-splicing factor ATP-dependent RNA helicase DHX15
coiled-coil domain containing 149, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain-containing protein 149 isoform X2
extracellular superoxide dismutase [Cu-Zn]
coiled-coil domain containing 149, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
coiled-coil domain-containing protein 149 isoform X3
coiled-coil domain containing 149, transcript variant X1
coiled-coil domain-containing protein 149 isoform X1
coiled-coil domain containing 149, transcript variant X4
coiled-coil domain-containing protein 149 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 8 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase, transcript variant X4
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
O-phosphoseryl-tRNA(Sec) selenium transferase isoform X1
O-phosphoseryl-tRNA(Sec) selenium transferase isoform X4
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
O-phosphoseryl-tRNA(Sec) selenium transferase isoform X2
Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase, transcript variant X3
O-phosphoseryl-tRNA(Sec) selenium transferase isoform X3
phosphatidylinositol 4-kinase type 2 beta, transcript variant X2
phosphatidylinositol 4-kinase type 2 beta, transcript variant X1
phosphatidylinositol 4-kinase type 2-beta isoform X1
phosphatidylinositol 4-kinase type 2-beta isoform X2
phosphatidylinositol 4-kinase type 2 beta, transcript variant X3
phosphatidylinositol 4-kinase type 2-beta isoform X3
zinc finger CCHC-type containing 4, transcript variant X4
zinc finger CCHC-type containing 4, transcript variant X2
zinc finger CCHC-type containing 4, transcript variant X3
zinc finger CCHC-type containing 4, transcript variant X1
rRNA N6-adenosine-methyltransferase ZCCHC4 isoform X1
rRNA N6-adenosine-methyltransferase ZCCHC4 isoform X3
rRNA N6-adenosine-methyltransferase ZCCHC4 isoform X4
rRNA N6-adenosine-methyltransferase ZCCHC4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 54% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00432
COORDINATES: nucleotide motif:Rfam:12.0:RF01210
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
sodium-dependent phosphate transport protein 2B, transcript variant X1
sodium-dependent phosphate transport protein 2B isoform X1
sodium-dependent phosphate transport protein 2B, transcript variant X2
sodium-dependent phosphate transport protein 2B isoform X2
sodium-dependent phosphate transport protein 2B-like
SEL1L family member 3, transcript variant X1
SEL1L family member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X2
recombining binding protein suppressor of hairless isoform X2
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X1
recombining binding protein suppressor of hairless isoform X1
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X3
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X4
recombining binding protein suppressor of hairless isoform X3
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X5
recombination signal binding protein for immunoglobulin kappa J region, transcript variant X6
recombining binding protein suppressor of hairless isoform X4
recombining binding protein suppressor of hairless isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 11 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
TBC1 domain family member 19, transcript variant X2
TBC1 domain family member 19, transcript variant X1
TBC1 domain family member 19, transcript variant X4
TBC1 domain family member 19, transcript variant X3
stromal interaction molecule 2, transcript variant X1
stromal interaction molecule 2, transcript variant X2
stromal interaction molecule 2 isoform X1
stromal interaction molecule 2 isoform X2
translation machinery-associated protein 7-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
pre-mRNA-processing factor 40 homolog A-like
LOW QUALITY PROTEIN: pre-mRNA-processing factor 40 homolog A-like
ras-related C3 botulinum toxin substrate 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2, transcript variant X3
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2, transcript variant X1
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2, transcript variant X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 isoform X2
arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 32% coverage of the annotated genomic feature by RNAseq alignments
NACHT and WD repeat domain containing 2, transcript variant X1
NACHT and WD repeat domain-containing protein 2 isoform X1
NACHT and WD repeat domain containing 2, transcript variant X2
NACHT and WD repeat domain containing 2, transcript variant X3
NACHT and WD repeat domain-containing protein 2 isoform X2
NACHT and WD repeat domain-containing protein 2 isoform X3
chromosome 17 C4orf19 homolog, transcript variant X4
chromosome 17 C4orf19 homolog, transcript variant X2
chromosome 17 C4orf19 homolog, transcript variant X1
chromosome 17 C4orf19 homolog, transcript variant X3
chromosome 17 C4orf19 homolog, transcript variant X5
transcription elongation factor SPT5-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transcription elongation factor SPT5-like
TBC1 domain family member 1, transcript variant X1
TBC1 domain family member 1, transcript variant X2
TBC1 domain family member 1, transcript variant X3
TBC1 domain family member 1, transcript variant X6
TBC1 domain family member 1, transcript variant X4
TBC1 domain family member 1, transcript variant X5
uncharacterized LOC122673552, transcript variant X2
uncharacterized LOC122673552, transcript variant X1
uncharacterized LOC122673552, transcript variant X3
jupiter microtubule associated homolog 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 mRNAs, 105 ESTs, 6 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
tubulin alpha-1B chain-like, transcript variant X2
tubulin alpha-1B chain-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 883 ESTs, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Kruppel like factor 3, transcript variant X2
Kruppel like factor 3, transcript variant X1
uncharacterized LOC122673575, transcript variant X2
uncharacterized LOC122673575, transcript variant X1
uncharacterized LOC122673575, transcript variant X3
toll like receptor 10, transcript variant X1
toll like receptor 10, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 13 ESTs, 45 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
LOW QUALITY PROTEIN: toll-like receptor 1
toll like receptor 6, transcript variant X2
toll like receptor 6, transcript variant X4
toll like receptor 6, transcript variant X1
toll like receptor 6, transcript variant X3
transfer RNA arginine (anticodon GCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
family with sequence similarity 114 member A1, transcript variant X2
family with sequence similarity 114 member A1, transcript variant X1
family with sequence similarity 114 member A1, transcript variant X3
transmembrane protein 156, transcript variant X2
transmembrane protein 156, transcript variant X1
transmembrane protein 156, transcript variant X3
kelch like family member 5, transcript variant X5
kelch like family member 5, transcript variant X3
kelch like family member 5, transcript variant X1
kelch like family member 5, transcript variant X2
kelch like family member 5, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
WD repeat domain 19, transcript variant X1
WD repeat domain 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
WD repeat-containing protein 19 isoform X1
WD repeat domain 19, transcript variant X3
WD repeat-containing protein 19 isoform X2
lipoic acid synthetase, transcript variant X1
lipoic acid synthetase, transcript variant X2
lipoyl synthase, mitochondrial isoform X1
lipoyl synthase, mitochondrial isoform X2
UDP-glucose 6-dehydrogenase, transcript variant X2
UDP-glucose 6-dehydrogenase, transcript variant X1
small integral membrane protein 14, transcript variant X1
small integral membrane protein 14, transcript variant X2
eukaryotic translation initiation factor 1-like
ubiquitin conjugating enzyme E2 K, transcript variant X2
ubiquitin conjugating enzyme E2 K, transcript variant X3
ubiquitin conjugating enzyme E2 K, transcript variant X4
ubiquitin-conjugating enzyme E2 K isoform X2
ubiquitin-conjugating enzyme E2 K isoform X3
ubiquitin conjugating enzyme E2 K, transcript variant X1
ubiquitin-conjugating enzyme E2 K isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
ubiquitin-conjugating enzyme E2 K isoform X4
PDS5 cohesin associated factor A, transcript variant X2
PDS5 cohesin associated factor A, transcript variant X1
PDS5 cohesin associated factor A, transcript variant X3
sister chromatid cohesion protein PDS5 homolog A
NEDD4 binding protein 2, transcript variant X3
NEDD4 binding protein 2, transcript variant X5
NEDD4 binding protein 2, transcript variant X1
NEDD4 binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
NEDD4 binding protein 2, transcript variant X4
ras homolog family member H, transcript variant X2
ras homolog family member H, transcript variant X1
ras homolog family member H, transcript variant X3
cholinergic receptor nicotinic alpha 9 subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
neuronal acetylcholine receptor subunit alpha-9
transfer RNA glycine (anticodon GCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
RNA binding motif protein 47, transcript variant X10
RNA binding motif protein 47, transcript variant X12
RNA binding motif protein 47, transcript variant X1
RNA binding motif protein 47, transcript variant X2
RNA binding motif protein 47, transcript variant X4
RNA binding motif protein 47, transcript variant X11
RNA binding motif protein 47, transcript variant X3
RNA binding motif protein 47, transcript variant X5
RNA binding motif protein 47, transcript variant X6
RNA binding motif protein 47, transcript variant X9
RNA binding motif protein 47, transcript variant X8
RNA binding motif protein 47, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
NOP2/Sun RNA methyltransferase family member 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 10 ESTs, 3 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
amyloid beta precursor protein binding family B member 2, transcript variant X15
amyloid beta precursor protein binding family B member 2, transcript variant X7
amyloid beta precursor protein binding family B member 2, transcript variant X12
amyloid beta precursor protein binding family B member 2, transcript variant X8
amyloid beta precursor protein binding family B member 2, transcript variant X6
amyloid beta precursor protein binding family B member 2, transcript variant X3
amyloid beta precursor protein binding family B member 2, transcript variant X5
amyloid beta precursor protein binding family B member 2, transcript variant X4
amyloid beta precursor protein binding family B member 2, transcript variant X14
amyloid beta precursor protein binding family B member 2, transcript variant X10
amyloid beta precursor protein binding family B member 2, transcript variant X13
amyloid beta precursor protein binding family B member 2, transcript variant X11
amyloid beta precursor protein binding family B member 2, transcript variant X1
amyloid beta precursor protein binding family B member 2, transcript variant X2
amyloid beta precursor protein binding family B member 2, transcript variant X9
amyloid beta precursor protein binding family B member 2, transcript variant X16
amyloid-beta A4 precursor protein-binding family B member 2 isoform X10
amyloid-beta A4 precursor protein-binding family B member 2 isoform X9
amyloid-beta A4 precursor protein-binding family B member 2 isoform X5
amyloid-beta A4 precursor protein-binding family B member 2 isoform X2
amyloid-beta A4 precursor protein-binding family B member 2 isoform X8
amyloid-beta A4 precursor protein-binding family B member 2 isoform X7
amyloid-beta A4 precursor protein-binding family B member 2 isoform X6
amyloid-beta A4 precursor protein-binding family B member 2 isoform X4
amyloid-beta A4 precursor protein-binding family B member 2 isoform X3
amyloid-beta A4 precursor protein-binding family B member 2 isoform X1
amyloid-beta A4 precursor protein-binding family B member 2 isoform X11
ubiquitin carboxyl-terminal hydrolase isozyme L1
LIM and calponin homology domains 1, transcript variant X1
LIM and calponin homology domains 1, transcript variant X4
LIM and calponin homology domains 1, transcript variant X6
LIM and calponin homology domains 1, transcript variant X3
LIM and calponin homology domains 1, transcript variant X5
LIM and calponin homology domains 1, transcript variant X8
LIM and calponin homology domains 1, transcript variant X2
LIM and calponin homology domains 1, transcript variant X9
LIM and calponin homology domains 1, transcript variant X7
LIM and calponin homology domains 1, transcript variant X13
LIM and calponin homology domains 1, transcript variant X14
LIM and calponin homology domains 1, transcript variant X15
LIM and calponin homology domains 1, transcript variant X16
LIM and calponin homology domains-containing protein 1 isoform X1
LIM and calponin homology domains-containing protein 1 isoform X4
LIM and calponin homology domains-containing protein 1 isoform X6
LIM and calponin homology domains-containing protein 1 isoform X3
LIM and calponin homology domains-containing protein 1 isoform X5
LIM and calponin homology domains-containing protein 1 isoform X8
LIM and calponin homology domains-containing protein 1 isoform X2
LIM and calponin homology domains-containing protein 1 isoform X9
LIM and calponin homology domains-containing protein 1 isoform X7
LIM and calponin homology domains-containing protein 1 isoform X12
LIM and calponin homology domains-containing protein 1 isoform X13
LIM and calponin homology domains-containing protein 1 isoform X14
LIM and calponin homology domains-containing protein 1 isoform X15
LIM and calponin homology domains 1, transcript variant X11
LIM and calponin homology domains 1, transcript variant X12
LIM and calponin homology domains-containing protein 1 isoform X11
LIM and calponin homology domains 1, transcript variant X10
LIM and calponin homology domains 1, transcript variant X17
LIM and calponin homology domains 1, transcript variant X18
LIM and calponin homology domains 1, transcript variant X19
LIM and calponin homology domains-containing protein 1 isoform X10
LIM and calponin homology domains-containing protein 1 isoform X16
LIM and calponin homology domains-containing protein 1 isoform X17
LIM and calponin homology domains-containing protein 1 isoform X18
solute carrier family 30 member 9, transcript variant X1
solute carrier family 30 member 9, transcript variant X2
BEN domain containing 4, transcript variant X1
BEN domain-containing protein 4 isoform X1
BEN domain containing 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
BEN domain-containing protein 4 isoform X2
ATPase phospholipid transporting 8A1, transcript variant X1
ATPase phospholipid transporting 8A1, transcript variant X3
ATPase phospholipid transporting 8A1, transcript variant X2
phospholipid-transporting ATPase IA isoform X1
phospholipid-transporting ATPase IA isoform X3
phospholipid-transporting ATPase IA isoform X2
glutaredoxin and cysteine rich domain containing 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 58% coverage of the annotated genomic feature by RNAseq alignments
glutaredoxin domain-containing cysteine-rich protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
potassium channel tetramerization domain containing 8, transcript variant X1
potassium channel tetramerization domain containing 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Yip1 domain family member 7, transcript variant X2
Yip1 domain family member 7, transcript variant X3
Yip1 domain family member 7, transcript variant X1
Yip1 domain family member 7, transcript variant X4
GTP binding elongation factor GUF1, transcript variant X1
translation factor GUF1, mitochondrial isoform X1
GTP binding elongation factor GUF1, transcript variant X2
translation factor GUF1, mitochondrial isoform X2
glucosamine-6-phosphate deaminase 2, transcript variant X1
glucosamine-6-phosphate deaminase 2, transcript variant X2
leucine zipper protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 8 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
leucine zipper protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
leucine zipper protein 1-like isoform X2
leucine zipper protein 1-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid type A receptor subunit gamma1
gamma-aminobutyric acid receptor subunit gamma-1
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X1
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X3
gamma-aminobutyric acid type A receptor subunit alpha2, transcript variant X2
gamma-aminobutyric acid receptor subunit alpha-2 isoform X1
gamma-aminobutyric acid receptor subunit alpha-2 isoform X3
gamma-aminobutyric acid receptor subunit alpha-2 isoform X2
cytochrome c oxidase subunit 7B2, mitochondrial
gamma-aminobutyric acid type A receptor subunit alpha4
gamma-aminobutyric acid receptor subunit alpha-4
gamma-aminobutyric acid type A receptor subunit beta1, transcript variant X1
gamma-aminobutyric acid receptor subunit beta-1 isoform X1
gamma-aminobutyric acid type A receptor subunit beta1, transcript variant X2
gamma-aminobutyric acid receptor subunit beta-1 isoform X2
ATPase phospholipid transporting 10D (putative), transcript variant X1
ATPase phospholipid transporting 10D (putative), transcript variant X2
phospholipid-transporting ATPase VD isoform X1
phospholipid-transporting ATPase VD isoform X2
corin, serine peptidase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
corin, serine peptidase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
corin, serine peptidase, transcript variant X1
corin, serine peptidase, transcript variant X5
corin, serine peptidase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
corin, serine peptidase, transcript variant X6
atrial natriuretic peptide-converting enzyme isoform X5
atrial natriuretic peptide-converting enzyme isoform X2
atrial natriuretic peptide-converting enzyme isoform X4
atrial natriuretic peptide-converting enzyme isoform X3
atrial natriuretic peptide-converting enzyme isoform X1
atrial natriuretic peptide-converting enzyme isoform X6
corin, serine peptidase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
atrial natriuretic peptide-converting enzyme isoform X7
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
nuclear transcription factor, X-box binding like 1, transcript variant X6
nuclear transcription factor, X-box binding like 1, transcript variant X4
nuclear transcription factor, X-box binding like 1, transcript variant X3
nuclear transcription factor, X-box binding like 1, transcript variant X7
nuclear transcription factor, X-box binding like 1, transcript variant X5
nuclear transcription factor, X-box binding like 1, transcript variant X2
nuclear transcription factor, X-box binding like 1, transcript variant X1
NF-X1-type zinc finger protein NFXL1 isoform X2
NF-X1-type zinc finger protein NFXL1 isoform X1
NF-X1-type zinc finger protein NFXL1 isoform X4
NF-X1-type zinc finger protein NFXL1 isoform X3
nuclear transcription factor, X-box binding like 1, transcript variant X9
nuclear transcription factor, X-box binding like 1, transcript variant X8
NF-X1-type zinc finger protein NFXL1 isoform X6
NF-X1-type zinc finger protein NFXL1 isoform X5
cyclic nucleotide gated channel subunit alpha 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
NIPA like domain containing 1, transcript variant X1
NIPA like domain containing 1, transcript variant X2